Dear colleague,
The World Health Organization (WHO) is initiating a comprehensive analysis of the most needed medicines for children to inform the review of the Essential Medicines List for children (EMLc). As a member of the WHO-led network Global Accelerator for Paediatric formulations (GAP-f), Penta is collaborating with this review.
We need your help as a health care professional prescribing, preparing, or administering medicines to children to understand:
- Which paediatric formulations do you find most problematic and why?
- Which medicines are missing or are not accessible for the children you care for and why?
To start the survey click here: https://bit.ly/2SS31Im.
The survey should not take more than 15 minutes of your time. You can save your responses and return to complete them at any time until the survey is closed on August 31st, 2021.
Thank you in advance for contributing to the survey completion.
Please do not hesitate to share the link to the survey with other colleagues who may provide a knowledgeable opinion.
We remain available to clarify any doubt you may have on the survey and will be happy to assist and receive your questions at the following email address:
We really appreciate your input!
Carlo Giaquinto – President of Penta Foundation and Marc Lallemant – GAP-f Clinical Research Working Group leader
